Pharmacometric Network BeNeLux (PNB)

November 22, 2018
Breda, The Netherlands

Join us at the Pharmacometric Network BeNeLux meeting in Breda, The Netherlands, at the Apollo Hotel Breda City Centre. Certara is a sponsor.

  • Certara’s Piet van der Graaf will be presenting “How QSP Brings Value to Drug Development: A Tutorial” from 1:00–1:40 pm.
  • Certara’s Christian Maass will be...


Using Realistic Covariates with New Trial Simulator to Optimize Meropenem Dosing in Renally-impaired Children

November 27, 2018
In this webinar, see the new Trial Simulator v2.3 in action as Dr. Edward Nehus of Cincinnati Children’s Hospital and Dr. Mark Lovern, VP of Integrated Drug Development at Certara, evaluate target attainment of meropenem in various age groups and fluid overload in children receiving continuous renal replacement therapy (CRRT), reconstructing a...

What’s New in the Simcyp Simulator v18?

December 5, 2018
Sponsors and regulatory agencies routinely use physiologically-based pharmacokinetic (PBPK) modeling and simulation to assist in dose selection and inform product labeling. Certara’s PBPK platform, the Simcyp® Simulator, links in vitro data to in vivo ADME (absorption, distribution, metabolism, and excretion) and...



Learn More LinkedIn Twitter Facebook Email
Powered by Translations.com GlobalLink OneLink Software